Navigation Links
Axsun Technologies Announces Strategic Supply Agreement for Integrated OCT Engines with Lantis Laser for Dental Imaging Applications
Date:6/3/2008

BILLERICA, Mass, June 3 /PRNewswire/ -- Axsun Technologies Inc., a leading developer and manufacturer of advanced photonic components and subsystems, today announced that the company has entered into multi-million dollar Strategic Supply Agreement with Lantis Laser (Pink Sheets: LLSR). Under this multi-year exclusive agreement for Optical Coherence Tomography (OCT) dental imaging, Axsun will supply the Integrated Optical Coherence Tomography (OCT) Engine for Lantis' OCT Dental Imaging System (TM), to be introduced to the market in the first quarter of 2009.

"From Axsun's perspective, Lantis' introduction of OCT technology into dentistry provides us with an excellent opportunity to use our expertise in high-volume, cost-effective manufacturing to demanding specifications, for this very exciting worldwide market," said Dale Flanders, CEO of Axsun.

Stan Baron, President & CEO, concluding on this highly significant announcement, said that, "Axsun's Integrated OCT Engine enables Lantis to meet the criteria established for wide acceptance of its OCT System: high resolution, up to 10 times that of x-ray; real-time chair-side imaging; no radiation as it is light-based; and, a price that is affordable for most dentists. The technology has finally caught up with the application and put Lantis on target to introduce the OCT into the dental market in the first quarter of 2009."

About Axsun

Axsun Technologies, Inc., established in 1998, develops and manufactures advanced components and photonic subsystems used in industrial process control, test and measurement applications, and throughout the world's communication networks. Axsun has applied its expertise in micro-optics and precision engineering to pioneer an entirely new class of fully functional, miniaturized spectroscopic instruments and devices that enable dramatic improvements in quality, productivity, and performance across a variety of industries -- from pharmaceutical manufacturing an
'/>"/>

SOURCE Axsun Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging
2. ReBuilder Medical Technologies, Inc. Appears Recession Proof
3. Dawning Technologies, Inc. and Medical Automation Systems, Inc. to Develop a Business Partnership
4. Oregon Cosmetic Vein Center Opens in Portland, Among First on West Coast to Offer Brand New, FDA-Approved Procedures and Technologies
5. VirtualHealth Technologies, Inc. Announces Management Appointment
6. Disc Motion Technologies Appoints Industry Veteran as New CEO
7. VNUS Medical Technologies to Present at FBR Capital Markets 12th Annual Spring Investor Conference
8. Accenx Technologies Joins Suns Authorized Subcontractor Program
9. OmniSonics Medical Technologies Announces First Patient Enrolled in SONIC II REGISTRY
10. Dawning Technologies, Inc. Releases JavaLin/PDI Portable Device Interface
11. OxyBand Technologies Signs Army Contract

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...hat women treated for breast cancer are at higher ...ts. Published in the December 15, 2009 issue of C...ncer Society, the study,s results indicate that br...t from additional therapies following surgery, suc... women with dense breast tissue are at increased r...
(Date:11/8/2009).... 8 Jon O,Brien, presid...statement about the passage of HR 3962: ,, "Be...oters a lot about core values. We in the prochoice... to overcome the struggles ordinary Americans have...cannot afford basic healthcare or have to choose b...
(Date:11/8/2009)...ouse Passage of Health Care Reform Bill ,, Cr...ove coverage for all Americans ,, HARRISBURG, ...UMMARY: Last night the United States House of Rep...gislation that would strengthen Medicare for senio...hat prices millions of Americans out of affordable...
(Date:11/8/2009)... take you out of the game later, doctors say , ...njuries are the talk of the NFL this season, sidel...nning back Willie Parker. , Officials at the Am...Academy of Podiatric Sports Medicine are warning a...fall sports like football and lacrosse. , "Many...
(Date:11/8/2009).... 7 Tonight the House o...e for America Act, landmark health reform legislat...quality, affordable, stable and secure health care...ome of the insurance industry,s worst practices, w...ut the deficit by $104 billion over ten years. Gro...
Breaking Medicine News(10 mins):Health News:Breast density associated with increased risk of cancer recurrence 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:Rx for Fall Foot Injuries 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3
...S doctors tend to prescribe unwanted, even possibl...ug makers in the name of lecture assignments. ...uld require drug makers to disclose payments made ...y other specialty. Not coincidentally prescri...
...ablish relationships, some physicians tell patient... travel experiences and political beliefs. Univer... investigation has found these personal disclosure... in about a third of patient visits. The disclosur...
...d the disheartening reasons behind her recent weig...ntly looking frail and emaciated in all her recent...too thin. The 'Tomb Raider' star revealed ... gone through a lot," the Daily Mail quoted Jolie,...
...y of Washington shows that the work intended for g...tate economy . The research was conducted b... geography; Amy Hagopian, professor in the School ...ration director of the Department of Global Health...
... patients with an alcohol-use disorder (AUD) are m... need it for a longer period of time. More than 3...ing intensive care per year in the United States, ...omic burden, costing a median 32,000 dollars to 56...
...iabetes, obesity and heart disease, chronic illnes... of death in poor countries by 2015. These...hich include malaria, AIDS and tuberculosis. ...tion and economy. The countries need to take up pr...
Other Medicine News:Health News:US Lawmakers Considering Legislation to Restrict Payments by Drug Companies to Doctors 2Health News:US Lawmakers Considering Legislation to Restrict Payments by Drug Companies to Doctors 3Health News:Personal Disclosure by Physician may Harm Patients 2Health News:Personal Disclosure by Physician may Harm Patients 3Health News:Personal Disclosure by Physician may Harm Patients 4Health News:Global Health Enriching the States Economy 2Health News:Patients With Alcohol Problem Need Mechanical Ventilation 2Health News:Non Communicable Diseases to Be the Cause of Deaths in Poor Countries by 2115-World Bank 2
(Date:11/6/2009)...N, Mass., Nov. 6 DUSA Ph...ermatology company that is developing and marketin...ther products focused on patients with common skin...nd Chief Executive Officer, will present a corpora...ummit 2009 on Tuesday, November 10, 2009 at 10:00 ...
(Date:11/6/2009)...Calif., Nov. 6 Kaiser Foundation H...P/H), and their subsidiaries reported today a comb...the quarter ended September 30, 2009, compared to ...perating income in the third quarter was $336 mill... of last year. Net non-operating income was $233 m...
(Date:11/6/2009)...Nov. 6 Caraco Pharmaceut...nched ketorolac tromethamine ophthalmic solution, ...nd Drug Administration (FDA) for Sun Pharma,s Abbr...ular® ophthalmic solution on the first day fo...lac is therapeutically equivalent to Acular® ...
Breaking Medicine Technology:Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity Testin 4994 1Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity Testin 4994 2Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity Testin 4994 3Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity Testin 4994 4Transave Announces Positive Phase II Results For Once Daily ARIKACE 28TM 29 in the Treatment of Non CF Bronchiectasis Patients Who Have Pseudomonas Lu 4992 1Transave Announces Positive Phase II Results For Once Daily ARIKACE 28TM 29 in the Treatment of Non CF Bronchiectasis Patients Who Have Pseudomonas Lu 4992 2Transave Announces Positive Phase II Results For Once Daily ARIKACE 28TM 29 in the Treatment of Non CF Bronchiectasis Patients Who Have Pseudomonas Lu 4992 3Transave Announces Positive Phase II Results For Once Daily ARIKACE 28TM 29 in the Treatment of Non CF Bronchiectasis Patients Who Have Pseudomonas Lu 4992 4Schering Plough Reports Long Term Vicriviroc Data From Phase II Open Label Extension Study in Treatment Experienced HIV Infected Patients 4990 1Schering Plough Reports Long Term Vicriviroc Data From Phase II Open Label Extension Study in Treatment Experienced HIV Infected Patients 4990 2Schering Plough Reports Long Term Vicriviroc Data From Phase II Open Label Extension Study in Treatment Experienced HIV Infected Patients 4990 3Schering Plough Reports Long Term Vicriviroc Data From Phase II Open Label Extension Study in Treatment Experienced HIV Infected Patients 4990 4Schering Plough Reports Long Term Vicriviroc Data From Phase II Open Label Extension Study in Treatment Experienced HIV Infected Patients 4990 5
...nc., a,biopharmaceutical company engaged in the di... treatment of immune-mediated diseases, announced ...modified version of TRX1,MTRX1011A, an anti-CD4 mo...hat has begun enrolling patients. The clinical tri...th single and multiple doses of MTRX1011A.,Under t...
...ffectiveness of Autologous Therapy, DUSSELDORF, G...entative study of knee osteoarthritis, published i...itis and Cartilage", confirm,the safety and effect...matory proteins obtained from the patient,s own bl...rchers at Heinrich Heine University in Dusseldorf ...
Other Medicine Technology:Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3Orthokine Treatment is Effective for Knee Arthritis, Even After Two Years 2
Snap-In Snap-Out®-II Strong Grasping Forceps Insert
Maryland Dissector, dual-incision
Optima III 45 Noninsulated Maryland Dissector
Palpation Probe, dual-incision
Medicine Products: